CSPC Pharmaceutical Group Ltd

Common Name
CSPC Pharmaceutical Group
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
21,400
Ticker
1093
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
CSPC Pharmaceutical Group Ltd. is a prominent player in the pharmaceutical industry, focusing on the research, development, manufacture, and commercialization of a wide array of pharmaceutical product...

CSPC Pharmaceutical Group Waste Data Preview

In 2023, CSPC Pharmaceutical Group conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into CSPC Pharmaceutical Group’s Generation of Hazardous and Non-Hazardous Waste

In 2023, CSPC Pharmaceutical Group generated a total of 38,769 metric tonnes of waste.

Of this amount, 33.59% of CSPC Pharmaceutical Group's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 66.41% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

CSPC Pharmaceutical Group’s Hazardous vs Non-Hazardous Waste Over Time

2020202120222023015 k30 k45 k60 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How CSPC Pharmaceutical Group reduced the environmental impact of its waste?

Since 2020, CSPC Pharmaceutical Group's total waste generation decreased by 19.71%, with an additional 19.31% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.

Over the same period, the share of hazardous waste decreased by 7.03%, yet rose by 13.67% in 2023, potentially signaling operational variability, temporary setbacks, or less effective hazardous waste mitigation in the short term.

Overall, CSPC Pharmaceutical Group's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.

Want Full Access to CSPC Pharmaceutical Group's Waste Management Dataset?
Sign Up